Problematic Use and Addiction in Primary Care

NCT ID: NCT06580756

Last Updated: 2024-12-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-09-30

Study Completion Date

2028-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The morbi-mortality and social cost of addictive disorders led the French authorities to set up a government plan in 2018 to combat drugs and addictive behavior (Interministerial mission to combat drugs and addictive behaviour - (MILDECA)). In particular, it encourages early detection, which is the first stage in a validated global approach to the management of addictive disorders. Improving early identification of addictive disorders in primary care would reduce morbidity and mortality and improve quality of life for patients with addictive disorders. The identification of use disorders should be systematic in primary care and was the subject of a recommendation in 2015. Numerous tests are cited in these recommendations, but few have actually been validated in primary care, and none has been shown to be feasible. For example, only 23% of GPs claim to systematically identify alcohol consumption.

Other primary care professionals (physiotherapists, nurses, midwives, dentists, pharmacists) also have a role to play in identifying addictive disorders. The evolution of their respective professions (delegation of tasks, creation of the profession of advanced practice nurse, medical assistants) and the recent reorganization of the practice framework, both in terms of practice structures and professional community organizations, involve them in a global multidisciplinary collaboration on patient care, particularly in the early identification of addictive disorders.

The hypothesis is that the difficulties in implementing tests to identify addictive disorders in primary care are linked to the lack of specific consideration of the needs of primary care patients and caregivers.

The overall aim of the study is to improve the early detection of addictive disorders through brief training for primary care healthcare professionals.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The project comprises three successive stages:

1. Design a training program with content tailored to primary care professionals;
2. Evaluate the feasibility and acceptability of the training;
3. Evaluate the implementation of this training program by comparing the incidence of addiction disorder detection by primary care professionals between a trained and an untrained group.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Addiction Disorders Primary Care

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

short training program

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

group intervention

Group with a brief training

Short training program

Intervention Type OTHER

Training in the early identification of addictive disorders in primary care

group control

Group without a brief training

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Short training program

Training in the early identification of addictive disorders in primary care

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* be a primary care professional (physiotherapists, nurses, midwives, dentists, pharmacists, General practitioner)
* in ambulatory practice. Recruitment will be carried out with the help of territorial professional health communities, to include practitioners practicing in conditions representative of the diversity of primary care practice.

GPs agreeing to take part will be divided into a control group and an intervention group, by drawing lots.

Exclusion Criteria

* Refusal to participate.
* The same participant may not be included in more than one stage.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Tours

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Maxime PAUTRAT

Role: PRINCIPAL_INVESTIGATOR

Tours university

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CPTS Lanmeur

Lanmeur, , France

Site Status

CPTS Sud Lochois

Ligueil, , France

Site Status

CPTS du Vendomois

Vendôme, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Maxime PAUTRAT

Role: CONTACT

Phone: 02 47 59 61 52

Email: [email protected]

Agathe EDELINE

Role: CONTACT

Phone: 02 47 82 89 77

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jean Yves LE RESTE

Role: primary

Maxime PAUTRAT

Role: primary

Alain AUMARECHAL

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DR230127-PAPRICA

Identifier Type: -

Identifier Source: org_study_id